Build your professional network on facebook via our app Go to app
 
Industry : Biotechnology Functional Area : New Technologies
Activity:  3 comments  517 views  last activity : 07 06 2010 20:18:04 +0000
 Refer 11
Share
 
 
 

BIOINFORMATICS, BIO - MEDICINE, AND GENE MANIPULATIONS IN DRUG DEVELOPMENT AND FUTURE MEDICAL CARE.


Bioinformatics is an emerging science which brings together the fields of Microbiology, Molecular Biology, Bio Technology and Genetics under the fold of computers and Software Advances in Computer Technology.The Bioinformatics is changing the entire concept, in future we may be compelled to view life and disease through the Chemistry of Genes. The facts about the human genome project were made public on the Internet by US department of energy and National Institute of Health, making the approach easier to any scientist or Doctor to learn the genomic science to utmost detail.

1. Basic findings of Genome Project:

2. Computer Speaks (Bio information):

3. Bioinformatics and Gene Therapy:

4. Bioinformatics and Proteomics:

5. Human Genome Project - Drugs of Future:
 
6. Genomic Based Drug Discovery:

7. Major Diseases on the List of Pharmaceutical Industry

to read more refer to the link mentioned above.

 Top Comment : Raghuram Bhuvanagiri   | 05 01 2008 05:50:47 +0000
Liquid filled in hard gelatin capsules – The new dosage delivery system Conventionally hard gelatin capsule has been used as a solid dosage form products, formulated either as powder or pellets. However, market demands new and different ways of formulation delivery to be developed and launched in minimum time period. Liquids filled into hard gelatin capsules can fulfill some of these demands and in particular to drugs for which the liquid and semi-solid filled capsule is particularly relevant. ·Drugs with poor bioavailability ·Drugs with low melting point ·Drug with low dose / High potency ·Drugs requiring better content uniformity ·Drugs requiring no Cross-contamination ·Drugs requiring increased critical stability ·Drugs with Sustained release Possibility ·Poor bioavailability: The bioavailability of the poorly water-soluble drug dioxin could be significantly enhanced when formulated as a liquid in a hard gelatin capsule. This increases the effectiveness of the drug. ·Low melting point: Materials which have low melting points or are liquid at room temperature present difficulties when formulating as dry powders, often requiring high concentrations of excipient to avoid processing problems. The manufacturing process can be considerably simplified (five step process to manufacture a tablet can be reduced to a simple mixing and filling operation) by filling as a hot melt into a hard gelatin capsule. Consumer acceptance was also enhanced due to the smaller size of the final dosage form. ·Low dose / High potency: Drugs in this category present two main challenges; how to achieve acceptable content uniformity and how to control cross-contamination and worker protection. This type of drugs can be delivered easily in liquid dosage in hard gelatin capsule. ·Content uniformity: The liquid filling operation is capable of achieving fill weight variations of < 1%. If a drug sub-stance is in solution or is uniformly dispersed in a liquid vehicle then it follows that good drug content uniformity can also be achieved (Triamterene at 25µg.) ·Cross-contamination: Companies manufacturing solid dosage forms of hormones and cytotoxic agents from powders are forced to install extremely elaborate systems to reduce contamination. Incorporation of the highly potent agent into a liquid for filling into a hard gelatin capsule can reduce the dangers when working with such drugs. ·Critical stability: Sensitivity to moisture is an aspect of formulation, which can be minimized by incorporating the drug into either a hydrophilic or lipophilic matrix. For example, the antibiotic vancomycin hydrochloride is highly hygroscopic and to achieve acceptable stability it needed to be formulated as a lyophilized powder for reconstitution. (Hard gelatin capsule filled with a PEG 6000 matrix). ·Sustained release: By choosing an appropriate excipient the release rate of an active can be modified. For example Gelucire, which is available as a semi-solid with a range of melting points and HLB values, can be mixed to obtain different drug release rates compared the bioavailability of an oily semi-solid matrix of captopril in hard gelatin capsules with that of a tablet. Looking beyond the formulation advantages: ·Novel drug delivery system (NDDS) This new technology of delivering the drug in hard gelatin can circumvent the existing patenting of the drug in soft gel or any other form. This will be a novel drug delivery system for the brand owner and the product can be launched without any change in the formulation but only by delivering the drug in the hard gelatin. This not only opens new opportunity but also reduces the cost of the new product considerably and thus can add to the contribution. ·Brand advantage In the overcrowded market where there is a jungle of products of similar types with soft gelatin as the conventional delivery system for the liquid product, this technology unfolds new opportunity for building unique brand for the liquid based formulations. This new delivery system empowers the product managers with a tool for re-launching existing products and launching new products with better results and customer acceptance. PARAMETER HARD GEL SOFT GEL Bio-Availability Good Good Stability Good Good Losses No losses in formulation High (up to 6%). Combination Filling(Liquids + pellets) Possible Not possible Hot melts Up to 70 degree centigrade Up to 35 degree centigrade Gelatin preparation Not applicable Yes Gelling time Not applicable Up to 10 hours. Tumble Drying Not applicable Yes. Drying Under 10 minutes in band sealing machine Up to 60 hours for soft gel line. Shell product interactions No such issue This is a concern . Combination filling Liquids & pellets possible Not possible. Shrinkage No such issue Non uniform during long period of drying process. Process Simple Operation, complex & messy . In house control Yes Out sourced. Gelatin wastage Not applicable Up to 40% in web. Social & health issues No such issue Gelatin ribbon wastage generated during the process has to be buried directly or buried after incineration. Additional Information: 1.Power consumption is more than 5 Times in soft gel plant to that of Liquid Encapsulation in Hard capsule 2.Man Power cost in soft gel is six times in hard capsule, as soft gel line is a 24-hour operation, unlike soft gel, which is a single shift operation. 3.Wastages are high in soft gel process if there are sudden stoppages in production line. Advantages of Liquid Filling in Hard Capsules from Formulation & Market perspective Formulation Perspective Time release formulation possible Alternative solution for stability problems Improved bioavailability Super - critical uniformity Incompatible drugs in single dose Combination Fills- Liquid & Pellet Lower investment for R & D Semi Solid Matrix forms cover formulations with wide range of viscosities. Use excepients with melting points up to 70°C. Combination Filling: Liquid & Pellet Brings operation in-house Simplified Process, operator friendly Preventive maintenance – convenient The "clean label" concept, i.e. no additives, fewer excipients, no allergens, no GMOs. Marketing perspective Liquid Appeal span all supplement products & demographic Groups . Product security as dosage & formulation are tamper resistant Patent Protection Protection against counterfeit NDDS offers one more platform for marketing activities as an alternative dosage delivery system HPMC Capsules will provide the right alternative for TSE/BSE free capsules Extending the life of a brand Cost effective / no wastage Brand shield Attractive new dosage form enhances branding Raghuram Bhuvanagiri Product Manager Pam Pharmaceuticals & Allied Machuinery co. Pvt. Ltd
 
TrackBack URL:
3 comments on "Bioinformatics, Bio-medicine and Gene Manipulation in Drug Development and Future Medical Care"
  Commented by  Samir Nigam, Sr. Software Engineer , SRM TECHSOL Pvt. Ltd.    | 07 27 2008 22:58:02 +0000
nice one.
Rating : +1 
Liquid filled in hard gelatin capsules – The new dosage delivery system

Conventionally hard gelatin capsule has been used as a solid dosage form products, formulated either as powder or pellets. However, market demands new and different ways of formulation delivery to be developed and launched in minimum time period. Liquids filled into hard gelatin capsules can fulfill some of these demands and in particular to drugs for which the liquid and semi-solid filled capsule is particularly relevant.

·Drugs with poor bioavailability
·Drugs with low melting point
·Drug with low dose / High potency
·Drugs requiring better content uniformity
·Drugs requiring no Cross-contamination
·Drugs requiring increased critical stability
·Drugs with Sustained release Possibility

·Poor bioavailability: The bioavailability of the poorly water-soluble drug dioxin could be significantly enhanced when formulated as a liquid in a hard gelatin capsule. This increases the effectiveness of the drug. 

·Low melting point: Materials which have low melting points or are liquid at room temperature present difficulties when formulating as dry powders, often requiring high concentrations of excipient to avoid processing problems. The manufacturing process can be considerably simplified (five step process to manufacture a tablet can be reduced to a simple mixing and filling operation) by filling as a hot melt into a hard gelatin capsule.  Consumer acceptance was also enhanced due to the smaller size of the final dosage form.  

·Low dose / High potency: Drugs in this category present two main challenges; how to achieve acceptable content uniformity and how to control cross-contamination and worker protection. This type of drugs can be delivered easily in liquid dosage in hard gelatin capsule. 

·Content uniformity: The liquid filling operation is capable of achieving fill weight variations of < 1%. If a drug sub-stance is in solution or is uniformly dispersed in a liquid vehicle then it follows that good drug content uniformity can also be achieved (Triamterene at 25µg.)

·Cross-contamination: Companies manufacturing solid dosage forms of hormones and cytotoxic agents from powders are forced to install extremely elaborate systems to reduce contamination. Incorporation of the highly potent agent into a liquid for filling into a hard gelatin capsule can reduce the dangers when working with such drugs. 

·Critical stability: Sensitivity to moisture is an aspect of formulation, which can be minimized by incorporating the drug into either a hydrophilic or lipophilic matrix. For example, the antibiotic vancomycin hydrochloride is highly hygroscopic and to achieve acceptable stability it needed to be formulated as a lyophilized powder for reconstitution. (Hard gelatin capsule filled with a PEG 6000 matrix). 

·Sustained release: By choosing an appropriate excipient the release rate of an active can be modified. For example Gelucire, which is available as a semi-solid with a range of melting points and HLB values, can be mixed to obtain different drug release rates compared the bioavailability of an oily semi-solid matrix of captopril in hard gelatin capsules with that of a tablet. 

Looking beyond the formulation advantages:

·Novel drug delivery system (NDDS) 
This new technology of delivering the drug in hard gelatin can circumvent the existing patenting of the drug in soft gel or any other form. This will be a novel drug delivery system for the brand owner and the product can be launched without any change in the formulation but only by delivering the drug in the hard gelatin. This not only opens new opportunity but also reduces the cost of the new product considerably and thus can add to the contribution.

·Brand advantage
In the overcrowded market where there is a jungle of products of similar types with soft gelatin as the conventional delivery system for the liquid product, this technology unfolds new opportunity for building unique brand for the liquid based formulations.  This new delivery system empowers the product managers with a tool for re-launching existing products and launching new products with better results and customer acceptance.







 

PARAMETER 	HARD GEL		SOFT GEL
Bio-Availability	Good 	Good 
Stability	Good	Good
Losses	No losses in formulation	High (up to 6%).
Combination Filling(Liquids + pellets)	Possible	Not possible
Hot melts	Up to 70 degree centigrade	Up to 35 degree centigrade
Gelatin preparation	Not applicable	Yes
Gelling time	Not applicable	Up to 10 hours.
Tumble Drying	Not applicable	Yes.
Drying	Under 10 minutes in band sealing machine	Up to 60 hours for soft gel line.
Shell product interactions	No such issue	This is a concern .
Combination filling	Liquids & pellets possible	Not possible.
Shrinkage	No such issue	Non uniform during long period of drying process.
Process	Simple	Operation, complex & messy .
In house control	Yes	Out sourced.
Gelatin wastage	Not applicable	Up to 40% in web.
Social & health issues	No such issue	Gelatin ribbon wastage generated during the process has to be   buried directly or buried after incineration.

Additional Information:
1.Power consumption is more than 5 Times in soft gel plant to that of Liquid Encapsulation in Hard capsule 
2.Man Power cost in soft gel is   six times in hard capsule, as soft gel line is a 24-hour operation, unlike soft gel, which is a single shift operation.
3.Wastages are high in soft gel process if there are sudden stoppages in production line.














Advantages of Liquid Filling in Hard Capsules from Formulation & Market perspective 

Formulation Perspective 

Time release formulation possible
Alternative solution for stability problems
Improved bioavailability 
Super - critical uniformity
Incompatible drugs in single dose
Combination Fills- Liquid & Pellet
Lower investment for R & D
Semi Solid Matrix forms cover formulations with wide range of viscosities. 
Use excepients with melting points up to 70°C.
Combination Filling: Liquid & Pellet
Brings operation in-house 
Simplified Process, operator friendly
Preventive maintenance – convenient
The "clean label" concept, i.e. no additives, fewer excipients, no allergens, no GMOs.  


Marketing perspective 

Liquid Appeal span all supplement products & demographic Groups .
Product security as dosage & formulation are tamper resistant
Patent Protection
Protection against counterfeit
NDDS offers one more   platform for marketing activities as an alternative dosage delivery system
HPMC Capsules will provide the right   alternative for TSE/BSE free capsules
Extending the life of a brand
Cost effective / no wastage
Brand shield
Attractive new dosage form enhances branding

Raghuram Bhuvanagiri
Product Manager 
Pam Pharmaceuticals & Allied Machuinery co. Pvt. Ltd
  Commented by  Sovan Maiti, Product Development Manager, Care Biomedicals    | 04 25 2008 02:51:35 +0000
i would like to give some inputs of stages of drug development.
The drug development process involves three stages:

    * Drug discovery

    * Drug development

    * Drug delivery
and drug discovery mainly deals with gene manipulation and genemoics
Add your comment on "Bioinformatics, Bio-medicine and Gene Manipulation in Drug Development and Future Medical Care"

Rate:
Submit
 
Viewers also viewed
Every year we hear about crores of rupees sanctioned  and utilised for medical equipment...
 
8 referals 9 arguments, 65 views
Is it Ritual to spiritual or spirit tospiritual or " Concept of higher human values through...
 
1152 referals 23 arguments, 272 views
Yes vs No
 
957 referals 11 arguments, 353 views
more...  
Recent Knowledge (101)
There is systemic failures in every field as we are yet to make use of IT to garner the systems...
 
413 referals 5 comments, 95 views
It has long been known that photovoltaic (PV) cells needn't always run on sunlight. Half a...
 
47 referals 5 comments, 53 views
As a recruiter of an IT Services Company, we are always looking for good recruiters and have had...
 
20 referals 3 comments, 12 views
more...  
More From Author
In vitro testing can replace animal testing to a certain extent but the technology still needs to be worked on in terms of specificity of results. The condition in in-vitro testing is not same as in any body and this leads to uncertainity in results....
yes it is very much important to conserve the medicinal plants that are in the list vanishing from the country, and most of the plants which are having medicinal properties is found mostly in India and no where else, it is very much necessary to...
In general Translational Medicine is the emerging and new medical practice and interventional epidemiology, this is a progression of Evidence-Based Medicine. It integrates all the research inputs from the basic sciences, social sciences and political...
more...